Globally, health leaders are faced with a proliferation of falsified and substandard medicines that threaten public health. Yet governments and health policy makers around the world need more data about the benefits of quality medicine to make strategic decisions about where to invest scarce resources. The USP Quality Institute will provide much-needed research and data to enable evidence-based policy decisions that can help increase the availability of quality medicines everywhere, helping to build a foundation for a healthier world.
The threat of bacteria and other microbes becoming resistant to treatment by antibiotics and other lifesaving drugs is a serious concern and public health threat. USP is working to help address this issue.